Luis Llamas

555 total citations
8 papers, 173 citations indexed

About

Luis Llamas is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Luis Llamas has authored 8 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Immunology. Recurrent topics in Luis Llamas's work include Click Chemistry and Applications (2 papers), Receptor Mechanisms and Signaling (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Luis Llamas is often cited by papers focused on Click Chemistry and Applications (2 papers), Receptor Mechanisms and Signaling (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Luis Llamas collaborates with scholars based in China, Switzerland and United States. Luis Llamas's co-authors include Jorge R. Quesada, Michael J. Keating, Herman I. Libshitz, Rishi K. Jain, Jason R. Thomas, Kurt R. Brunden, William F. Hodnick, Markus Schirle, Stephen M. Canham and Alain Stricker‐Krongrad and has published in prestigious journals such as Journal of Biological Chemistry, The American Journal of Medicine and Journal of Medicinal Chemistry.

In The Last Decade

Luis Llamas

8 papers receiving 167 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Llamas China 8 96 37 33 25 24 8 173
Kerrie B. Spencer United States 6 206 2.1× 27 0.7× 35 1.1× 19 0.8× 29 1.2× 6 283
Luke Green Switzerland 6 81 0.8× 39 1.1× 56 1.7× 19 0.8× 33 1.4× 7 200
Qianqian Ming United States 7 92 1.0× 25 0.7× 61 1.8× 5 0.2× 75 3.1× 13 212
Susan L. Strum United States 5 95 1.0× 34 0.9× 44 1.3× 21 0.8× 30 1.3× 6 222
Brandon Peiffer United States 6 130 1.4× 35 0.9× 41 1.2× 7 0.3× 51 2.1× 11 258
Mengli Yan China 7 94 1.0× 28 0.8× 29 0.9× 5 0.2× 9 0.4× 13 223
Laura Depta Germany 7 187 1.9× 51 1.4× 13 0.4× 13 0.5× 41 1.7× 17 240
Christian Eckhoff United States 9 235 2.4× 23 0.6× 18 0.5× 9 0.4× 20 0.8× 11 327
Fokje Zijlstra Netherlands 9 100 1.0× 11 0.3× 22 0.7× 4 0.2× 14 0.6× 11 182

Countries citing papers authored by Luis Llamas

Since Specialization
Citations

This map shows the geographic impact of Luis Llamas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Llamas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Llamas more than expected).

Fields of papers citing papers by Luis Llamas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Llamas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Llamas. The network helps show where Luis Llamas may publish in the future.

Co-authorship network of co-authors of Luis Llamas

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Llamas. A scholar is included among the top collaborators of Luis Llamas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Llamas. Luis Llamas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ding, Jian, Lulu Liu, Ying‐Ling Chiang, et al.. (2023). Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)–MYC Interaction. Journal of Medicinal Chemistry. 66(12). 8310–8323. 11 indexed citations
2.
Menon, Suchithra, Nadire R. Cochran, Qiong Wang, et al.. (2019). Bile acid analogues are activators of pyrin inflammasome. Journal of Biological Chemistry. 294(10). 3359–3366. 42 indexed citations
3.
Thomas, Jason R., et al.. (2017). A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates. Methods in molecular biology. 1647. 1–18. 18 indexed citations
4.
Peukert, Stefan, Richard L. Hughes, Jill Nunez, et al.. (2014). Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists. ACS Medicinal Chemistry Letters. 5(10). 1114–1118. 34 indexed citations
5.
Huck, Bayard R., Luis Llamas, Jianping Song, et al.. (2006). The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(11). 2891–2894. 12 indexed citations
6.
Huck, Bayard R., Luis Llamas, Jianping Song, et al.. (2006). The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist. Bioorganic & Medicinal Chemistry Letters. 16(15). 4130–4134. 22 indexed citations
7.
López-Santamaría, Mónica, Luis Llamas, H. J. Ree, et al.. (1988). Expression of Sialylated Leu-M1 Antigen in Histiocytosis X. American Journal of Clinical Pathology. 89(2). 211–216. 7 indexed citations
8.
Quesada, Jorge R., Michael J. Keating, Herman I. Libshitz, & Luis Llamas. (1983). Bone involvement in hairy cell leukemia. The American Journal of Medicine. 74(2). 228–231. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026